The Relative Strength (RS) Rating for Boston Scientific jumped into a new percentile Thursday, as it got a lift from 68 to 75.
How To Invest In Stocks In Both Bull And Bear Markets
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the top-performing stocks often have an RS Rating of over 80 in the early stages of their moves. See if Boston Scientific can continue to show renewed price strength and hit that benchmark.
Boston Scientific is not currently showing a potential buy point. See if the stock goes on to form a base that could kick off a new climb.
Earnings growth decreased last quarter from 34% to 21%, but revenue rose from 21% to 23%.
The company earns the No. 5 rank among its peers in the Medical-Products industry group. Insulet is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
